These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mast cell hyperplasia in chronic rejection after liver transplantation. O'Keeffe C, Baird AW, Nolan N, McCormick PA. Liver Transpl; 2002 Jan; 8(1):50-7. PubMed ID: 11799486 [Abstract] [Full Text] [Related]
6. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S. Transplantation; 2009 Feb 27; 87(4):606-14. PubMed ID: 19307800 [Abstract] [Full Text] [Related]
16. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation. Sieders E, Hepkema BG, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Bijleveld CM, van den Berg AP, Lems SP, Gouw AS, Slooff MJ. Liver Transpl; 2005 Dec 27; 11(12):1541-9. PubMed ID: 16315307 [Abstract] [Full Text] [Related]